MAPT and Alzheimer disease: Finally, these findings suggest that loss of BDNF that occurs downstream of abnormal increases in Aβ may increase vulnerability to neuronal dysfunction via tau and precipitate accelerated clinical disease progression in pre-dementia stages of AD.